Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Evaluation psychological distress in elderly cancer patients.

Carapezza L, Cordio S, Russo A, Paladina I, Paratore S, Longhitano L, Bordonaro R.

Ann Oncol. 2017 Oct;28 Suppl 6:vi85-vi86. doi: 10.1093/annonc/mdx434.014. No abstract available.

2.

Portable Intraoperative Computed Tomography Scan in Image-Guided Surgery for Brain High-grade Gliomas: Analysis of Technical Feasibility and Impact on Extent of Tumor Resection.

Barbagallo GMV, Palmucci S, Visocchi M, Paratore S, Attinà G, Sortino G, Albanese V, Certo F.

Oper Neurosurg (Hagerstown). 2016 Mar 1;12(1):19-30. doi: 10.1227/NEU.0000000000001112.

PMID:
29506245
3.

Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.

Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F.

Neurosurg Focus. 2014 Dec;37(6):E4. doi: 10.3171/2014.9.FOCUS14502.

PMID:
25434389
4.

Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways.

Paratore S, Pezzino S, Cavallaro S.

Curr Genomics. 2012 Jun;13(4):321-33. doi: 10.2174/138920212800793366.

5.

Gastric inhibitory polypeptide and its receptor are expressed in the central nervous system and support neuronal survival.

Paratore S, Ciotti MT, Basille M, Vaudry D, Gentile A, Parenti R, Calissano P, Cavallaro S.

Cent Nerv Syst Agents Med Chem. 2011 Sep 1;11(3):210-22.

PMID:
21919873
6.

Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis.

Guglielmelli P, Barosi G, Rambaldi A, Marchioli R, Masciulli A, Tozzi L, Biamonte F, Bartalucci N, Gattoni E, Lupo ML, Finazzi G, Pancrazzi A, Antonioli E, Susini MC, Pieri L, Malevolti E, Usala E, Occhini U, Grossi A, Caglio S, Paratore S, Bosi A, Barbui T, Vannucchi AM; AIRC-Gruppo Italiano Malattie Mieloproliferative (AGIMM) investigators.

Blood. 2011 Aug 25;118(8):2069-76. doi: 10.1182/blood-2011-01-330563. Epub 2011 Jul 1.

7.

Genomic analysis: toward a new approach in breast cancer management.

Cavallaro S, Paratore S, de Snoo F, Salomone E, Villari L, Buscarino C, Ferraù F, Banna G, Furci M, Strazzanti A, Cunsolo R, Pezzino S, Gangi S, Basile F.

Crit Rev Oncol Hematol. 2012 Mar;81(3):207-23. doi: 10.1016/j.critrevonc.2011.03.006. Epub 2011 Apr 20. Review.

PMID:
21511492
8.

Systems biology of apoptosis and survival: implications for drug development.

Pezzino S, Paratore S, Cavallaro S.

Curr Pharm Des. 2011;17(3):190-203. Review.

PMID:
21348833
9.

CXCR4 and CXCL12 immunoreactivities differentiate primary non-small-cell lung cancer with or without brain metastases.

Paratore S, Banna GL, D'Arrigo M, Saita S, Iemmolo R, Lucenti L, Bellia D, Lipari H, Buscarino C, Cunsolo R, Cavallaro S.

Cancer Biomark. 2011-2012;10(2):79-89. doi: 10.3233/CBM-2011-0232.

PMID:
22430135
10.

Drug target identification for neuronal apoptosis through a genome scale screening.

Tendi EA, Cunsolo R, Bellia D, Messina RL, Paratore S, Calissano P, Cavallaro S.

Curr Med Chem. 2010;17(26):2906-20. Review.

PMID:
20858172
11.

A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilic syndromes.

Intermesoli T, Delaini F, Acerboni S, Salmoiraghi S, Spinelli O, Guerini V, Vannucchi AM, Mappa S, Rossi G, Rossi V, Di Bona E, Paratore S, Carobbio A, Rambaldi A, Barbui T, Bassan R.

Br J Haematol. 2009 Dec;147(5):681-5. doi: 10.1111/j.1365-2141.2009.07893.x. Epub 2009 Sep 4.

PMID:
19735261
12.

Genes and pathways differentially expressed in the brains of Fxr2 knockout mice.

Cavallaro S, Paratore S, Fradale F, de Vrij FM, Willemsen R, Oostra BA.

Neurobiol Dis. 2008 Dec;32(3):510-20. doi: 10.1016/j.nbd.2008.09.008. Epub 2008 Sep 30.

PMID:
18930145
13.

Distribution of ADP-ribosylation factor-related protein 1 in mouse brain.

Paratore S, Parenti R, Cavallaro S.

Arch Ital Biol. 2008 Mar;146(1):53-61.

PMID:
18666447
14.

Cutting edge: MHC class I-Ly49 interaction regulates neuronal function.

Zohar O, Reiter Y, Bennink JR, Lev A, Cavallaro S, Paratore S, Pick CG, Brooker G, Yewdell JW.

J Immunol. 2008 May 15;180(10):6447-51.

15.

A natural antisense transcript against Rad18, specifically expressed in neurons and upregulated during beta-amyloid-induced apoptosis.

Parenti R, Paratore S, Torrisi A, Cavallaro S.

Eur J Neurosci. 2007 Nov;26(9):2444-57. Epub 2007 Oct 26.

PMID:
17970741
16.

Survivin expression in tuberous sclerosis complex cells.

Carelli S, Lesma E, Paratore S, Grande V, Zadra G, Bosari S, Di Giulio AM, Gorio A.

Mol Med. 2007 Mar-Apr;13(3-4):166-77.

17.

Genomic profiling of cortical neurons following exposure to beta-amyloid.

Paratore S, Parenti R, Torrisi A, Copani A, Cicirata F, Cavallaro S.

Genomics. 2006 Oct;88(4):468-79. Epub 2006 Aug 14.

18.

Degradation of insulin-like growth factor-I receptor occurs via ubiquitin-proteasome pathway in human lung cancer cells.

Carelli S, Di Giulio AM, Paratore S, Bosari S, Gorio A.

J Cell Physiol. 2006 Aug;208(2):354-62.

19.

Early genomics of learning and memory: a review.

Paratore S, Alessi E, Coffa S, Torrisi A, Mastrobuono F, Cavallaro S.

Genes Brain Behav. 2006 Apr;5(3):209-21. Review.

20.

Adding semantics to gene expression profiles: new tools for drug discovery.

Manganaro V, Paratore S, Alessi E, Coffa S, Cavallaro S.

Curr Med Chem. 2005;12(10):1149-60. Review.

PMID:
15892630
21.

[Esophago-gastric lesions caused by caustics].

Ranzato R, Busato T, Tropea A, D'Amico C, Paratore S.

Ann Ital Chir. 1992 Sep-Oct;63(5):605-9; discussion 610. Italian.

PMID:
1290365

Supplemental Content

Loading ...
Support Center